Similar articles

• An investigation of the association between ADRB2 gene polymorphisms and asthma in Kazakh population.

  Akparova A, Aripova A, Abishev M, Kazhiyakhmetova B, Pirmanova A, Bersimbaev R. Akparova A, et al. Clin Respir J. 2020 Jun;14(6):514-520. doi: 10.1111/crj.13160. Epub 2020 Feb 27. Clin Respir J. 2020. PMID: 32034992
• Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study.

  Ortega VE, Hawkins GA, Moore WC, Hastie AT, Ampleford EJ, Busse WW, Castro M, Chardon D, Erzurum SC, Israel E, Montealegre F, Wenzel SE, Peters SP, Meyers DA, Bleecker ER. Ortega VE, et al. Lancet Respir Med. 2014 Mar;2(3):204-13. doi: 10.1016/S2213-2600(13)70289-3. Epub 2014 Jan 27. Lancet Respir Med. 2014. PMID: 24621682 Free PMC article.
• Personalizing medicine: the single nucleotide polymorphism and the treatment of status asthmaticus.

  Stevens J, Notterman D. Stevens J, et al. Pediatr Crit Care Med. 2006 Jan;7(1):87-9. doi: 10.1097/01.pcc.0000194002.89906.42. Pediatr Crit Care Med. 2006. PMID: 16395083 No abstract available.
• Very important pharmacogene summary ADRB2.

  Litonjua AA, Gong L, Duan QL, Shin J, Moore MJ, Weiss ST, Johnson JA, Klein TE, Altman RB. Litonjua AA, et al. Pharmacogenet Genomics. 2010 Jan;20(1):64-9. doi: 10.1097/FPC.0b013e328333dae6. Pharmacogenet Genomics. 2010. PMID: 19927042 Free PMC article. Review. No abstract available.
• Association of arg16gly and gln27glu, b2-adrenergic receptor gene polymorphism with asthma. A systematic review and meta-analysis of case control studies.

  Khan I, Ul-Haq Z, Shaheen A, Zaman M, Ahmad N, Abbasi R, Siraj S. Khan I, et al. J Pak Med Assoc. 2018 Jan;68(1):90-97. J Pak Med Assoc. 2018. PMID: 29371726